Skip to main content
Veterinary Medicines

HATCHPAK IB H120

Authorised
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live

Auðkenning lyfsins

Heiti lyfs:
HATCHPAK IB H120
HATCHPAK IB H120 ΕΝΑΙΩΡΗΜΑ ΓΙΑ ΕΙΣΠΝΟΗ ΜΕ ΕΚΝΕΦΩΤΗ
Virkt efni:
Dýrategundir:
  • Kjúklingur (eins dags gamall)
Íkomuleið:
  • Til notkunar í augu og nef

Upplýsingar um lyfið

Virkt efni / Styrkur:
  • Aðeins í boði í English
    3.70
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Lyfjaform:
  • Þykkni fyrir lausn í eimgjafa
Withdrawal period by route of administration:
  • Oculonasal use
    • Kjúklingur (eins dags gamall)
      • All relevant tissues
        no withdrawal period
ATC flokkun (dýralyf):
  • QI01AD07
Staða markaðsleyfis:
  • Gilt
Authorised in:
Þessar upplýsingar eru ekki tiltækar fyrir þessa vöru.
Áletrun:

Viðbótarupplýsingar

Entitlement type:
  • Markaðsleyfi
Markaðsleyfishafi:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Framleiðandi sem ber ábyrgð á lokasamþykkt:
  • Boehringer Ingelheim Animal Health France
Ábyrgt yfirvald:
  • National Organization For Medicines
Markaðsleyfisnúmer:
  • 16238/27-2-2013/K-0166301
Dagsetning leyfisbreytingar:
Umsjónarland (RMS):
  • Frakkland
Númer verkferlis:
  • FR/V/0171/001
Þátttökulönd (CMS):
  • Belgía
  • Búlgaría
  • Kýpur
  • Tékkland
  • Þýskaland
  • Grikkland
  • Ungverjaland
  • Ítalía
  • Lettland
  • Litáen
  • Holland
  • Pólland
  • Rúmenía
  • Slóvakía
  • Slóvenía
  • Bretland (Norður-Írland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."